Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Multiple-dose, open-label parallel-group design in patients with mild, moderate or severe renal impairment and age (±7 years), sex and weight (±15% BMI) matched healthy subjects. * mild renal impairment: CrCl from 50 to ≤80 ml/min * moderate renal impairment: CrCl from 30 to \<50 ml/min * severe renal impairment: CrCl of \<30 ml/min